Quest Diagnostics | DGX - Ebitda

Aktienkurs
187.39
Täglich Wechseln
-3.45 -1.81%
Monatlich
-5.27%
Jährlich
5.89%
Q2 Prognose
188.66




Ebitda Veränderung Datum
Acadia Healthcare USD 144.22M 44.37M 2026-03
Agilent USD 540M 74M 2025-09
Baxter International USD -447M 873M 2025-12
Bruker USD 110M 101.6M 2026-03
Cardinal Health USD 1.09B 109M 2026-03
Centene USD 2.56B 3.47B 2026-03
Charles River Laboratories USD 229.8M 28.26M 2026-03
Cigna USD 2.86B 56M 2025-03
Community Health Systems USD 395M 19M 2025-12
CVS Health USD 5.83B 2.08B 2026-03
Danaher USD 1.92B 204M 2026-03
DaVita Healthcare Partners USD 659.83M 112.87M 2026-03
Elevance Health USD 4.21B 2.02B 2026-03
Encompass Health USD 348.8M 13.2M 2026-03
HCA USD 3.8B 312M 2026-03
Henry Schein USD 289M 2M 2026-03
Humana USD 2.06B 2.35B 2026-03
Illumina USD 469M 137M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
Laboratory Of America USD 605.6M 17.5M 2026-03
McKesson USD 1.88B 206M 2025-12
Mettler Toledo International USD 278.99M 100.24M 2026-03
Molina Healthcare USD 267M 385M 2026-03
Owens Minor USD 90.02M 2.15M 2025-12
Pediatrix Medical Group USD 65.84M 21.47M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Revvity USD 272.91M 24M 2026-03
Tenet Healthcare USD 1.16B 21M 2026-03
Thermo Fisher Scientific USD 2.7B 464M 2026-03
UnitedHealth USD 9.99B 8.5B 2026-03
Universal Health Services USD 678.67M 8.07M 2025-12
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 380.97M 85.83M 2025-12
Zoetis USD 939M 101M 2025-12